You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 9 No. 5, November 1963 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Abnormal Brain Permeability in CO2 Narcosis

MARK A. GOLDBERG, MD; CHARLES F. BARLOW, MD; LLOYD J. ROTH, MD

Arch Neurol. 1963;9(5):498-507.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

Carbon dioxide narcosis is a recognized phenomenon of the laboratory and in neurological practice.1 Hypercapnia is known to produce changes in the EEG,2 to dilate cerebral blood vessels,3 and to increase cerebral blood flow.4 The effect of hypercapnia on brain metabolism and permeability has been less intensively studied. In this report we have studied the effects of CO2 on brain permeability using sodium S35 sulfate and C14 urea as indicators, employing the methodologies of regional radioassay and autoradiography.

Methods

S35 sodium sulfate (Abbott Laboratories, Chicago, "carrier free") was administered intravenously to cats in the following dosage: 1 or 2 mc/kg for animals sacrificed after 5 min and 0.5 or 1 mc/kg for animals sacrificed after 1 and 6 hr. The differing dosage of radioactivity did not affect the results, but the higher radioactive dose was more satisfactory for metabolite separation. The . . . [Full Text PDF of this Article]


Author Affiliations

CHICAGO

From the Department of Medicine (Neurology) and the Department of Pharmacology, The University of Chicago.


Footnotes

Submitted for publication June 21, 1963; accepted July 16.

Presented in part before the Annual Meeting of the American Neurological Association, Atlantic City, June, 1963.

This work was supported by grant B-2331 of the Institute for Neurological Diseases and Blindness, National Institutes of Health.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1963 American Medical Association. All Rights Reserved.